[1]
Yadav, A. et al. 2014. De novo design and in-silico studies of novel bis-arylpiperazine derivatives as non-nucleoside inhibitors of HIV-1 reverse transcriptase. Journal of Pharmaceutical Chemistry. 1, 2 (Jul. 2014), 22–27. DOI:https://doi.org/10.14805/jphchem.2014.art10.